BridgeBio Pharma’s Phoenix Tissue Repair Provides Updates to its Recessive Dystrophic Epidermolysis Bullosa (RDEB) Program and Announces New Leadership Appointments

Ads

You May Also Like

Bavarian Nordic A/S – Notice Convening Ordinary General Meeting

COPENHAGEN, Denmark, 26 March, 2018 - Pursuant to Articles 10-14 of the Articles of ...

Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors

WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage ...

AIT Therapeutics Reports Financial Results for Fiscal Second Quarter 2019

PMA filing for treatment of PPHN expected in calendar second quarter 2019 Pivotal Bronchiolitis ...